HomeACXP • NASDAQ
add
Acurx Pharmaceuticals Inc
Previous close
$0.38
Day range
$0.38 - $0.40
Year range
$0.30 - $3.33
Market cap
8.50M USD
Avg Volume
205.53K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.78M | -45.61% |
Net income | -2.78M | 45.61% |
Net profit margin | — | — |
Earnings per share | -0.16 | 57.89% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.71M | -50.41% |
Total assets | 3.86M | -49.96% |
Total liabilities | 3.24M | 6.59% |
Total equity | 615.12K | — |
Shares outstanding | 22.04M | — |
Price to book | 9.50 | — |
Return on assets | -141.34% | — |
Return on capital | -424.17% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -2.78M | 45.61% |
Cash from operations | -2.25M | 46.39% |
Cash from investing | — | — |
Cash from financing | 194.55K | -95.79% |
Net change in cash | -2.06M | -587.33% |
Free cash flow | 1.69M | 551.65% |
About
CEO
Founded
2017
Website
Employees
4
